Hot Investor Mandate: Venture Arm of Family Office Invests Globally and Broadly Across All Life Science Sectors From Seed to Series C

24 Mar

A venture arm of a family office invests in all sectors of the life sciences, looking for companies that are 2-5 years from exit. The firm invests globally, although they have a preference for companies based in the UK and in Central/Eastern Europe. The firm invests from Seed-Series C, and generally will invest $1-5M per round.

The firm is both sector and indication agnostic, and is less focused on stage of development and more focused on time to exit, looking for companies with a strategy that will allow them to exit within 2-5 years after the investment.

The firm generally does not act as a lead investor. The firm does not generally take a board seat, and is usually a silent investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: